Global Liposome Technology Service 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI08245301

Publication Date:

August 20, 2024

Pages:

108

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

Liposome technology services refer to the professional technology that provides a series of services such as liposome preparation, optimization, drug encapsulation and evaluation. These services are mainly used in the fields of drug delivery, gene delivery, vaccine delivery and other fields to improve the bioavailability and targeting of drugs and reduce side effects and toxicity.
The global Liposome Technology Service market size is projected to grow from US$ 1154.3 million in 2023 to US$ 1610.8 million in 2030; it is expected to grow at a CAGR of 4.9% from 2024 to 2030.
The 鈥淟iposome Technology Service Industry Forecast鈥� looks at past sales and reviews total world Liposome Technology Service sales in 2023, providing a comprehensive analysis by region and market sector of projected Liposome Technology Service sales for 2024 through 2030. With Liposome Technology Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liposome Technology Service industry.
This Insight Report provides a comprehensive analysis of the global Liposome Technology Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liposome Technology Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Liposome Technology Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liposome Technology Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liposome Technology Service.
The application of liposomes as anti-tumor drug carriers is an important development trend. As drug carriers, liposomes can protect drugs from destruction by organisms, while improving the bioavailability and targeting of drugs and reducing side effects and toxicity. In the field of tumor treatment, liposomes are increasingly used and have become an important direction in anti-tumor drug research.
This report presents a comprehensive overview, market shares, and growth opportunities of Liposome Technology Service market by product type, application, key players and key regions and countries.
Segmentation by type
Liposome Production Services
Liposome Analysis and Characterization Services
Liposome Drug Delivery System Development Services
Others
Segmentation by application
Cancer Treatment
Gene Therapy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LIPOSOMA
CD Formulation
Creative Biostruct
Echelon Biosciences
Encapsula Nanosciences
Toshiba
FUJIFILM Pharmaceuticals USA
Lifeasible
PlantaCorp
LIPOMIZE SRL
Maison KOS脡
Microfluidics International Corporation
Exelead

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Liposome Technology Service 麻豆原创 Size 2019-2030
2.1.2 Liposome Technology Service 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Liposome Technology Service Segment by Type
2.2.1 Liposome Production Services
2.2.2 Liposome Analysis and Characterization Services
2.2.3 Liposome Drug Delivery System Development Services
2.2.4 Others
2.3 Liposome Technology Service 麻豆原创 Size by Type
2.3.1 Liposome Technology Service 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Liposome Technology Service 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Liposome Technology Service Segment by Application
2.4.1 Cancer Treatment
2.4.2 Gene Therapy
2.4.3 Others
2.5 Liposome Technology Service 麻豆原创 Size by Application
2.5.1 Liposome Technology Service 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Liposome Technology Service 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Liposome Technology Service 麻豆原创 Size by Player
3.1 Liposome Technology Service 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Liposome Technology Service Revenue by Players (2019-2024)
3.1.2 Global Liposome Technology Service Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Liposome Technology Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Liposome Technology Service by Regions
4.1 Liposome Technology Service 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Liposome Technology Service 麻豆原创 Size Growth (2019-2024)
4.3 APAC Liposome Technology Service 麻豆原创 Size Growth (2019-2024)
4.4 Europe Liposome Technology Service 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Liposome Technology Service 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Liposome Technology Service 麻豆原创 Size by Country (2019-2024)
5.2 Americas Liposome Technology Service 麻豆原创 Size by Type (2019-2024)
5.3 Americas Liposome Technology Service 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liposome Technology Service 麻豆原创 Size by Region (2019-2024)
6.2 APAC Liposome Technology Service 麻豆原创 Size by Type (2019-2024)
6.3 APAC Liposome Technology Service 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Liposome Technology Service by Country (2019-2024)
7.2 Europe Liposome Technology Service 麻豆原创 Size by Type (2019-2024)
7.3 Europe Liposome Technology Service 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liposome Technology Service by Region (2019-2024)
8.2 Middle East & Africa Liposome Technology Service 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Liposome Technology Service 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Liposome Technology Service 麻豆原创 Forecast
10.1 Global Liposome Technology Service Forecast by Regions (2025-2030)
10.1.1 Global Liposome Technology Service Forecast by Regions (2025-2030)
10.1.2 Americas Liposome Technology Service Forecast
10.1.3 APAC Liposome Technology Service Forecast
10.1.4 Europe Liposome Technology Service Forecast
10.1.5 Middle East & Africa Liposome Technology Service Forecast
10.2 Americas Liposome Technology Service Forecast by Country (2025-2030)
10.2.1 United States Liposome Technology Service 麻豆原创 Forecast
10.2.2 Canada Liposome Technology Service 麻豆原创 Forecast
10.2.3 Mexico Liposome Technology Service 麻豆原创 Forecast
10.2.4 Brazil Liposome Technology Service 麻豆原创 Forecast
10.3 APAC Liposome Technology Service Forecast by Region (2025-2030)
10.3.1 China Liposome Technology Service 麻豆原创 Forecast
10.3.2 Japan Liposome Technology Service 麻豆原创 Forecast
10.3.3 Korea Liposome Technology Service 麻豆原创 Forecast
10.3.4 Southeast Asia Liposome Technology Service 麻豆原创 Forecast
10.3.5 India Liposome Technology Service 麻豆原创 Forecast
10.3.6 Australia Liposome Technology Service 麻豆原创 Forecast
10.4 Europe Liposome Technology Service Forecast by Country (2025-2030)
10.4.1 Germany Liposome Technology Service 麻豆原创 Forecast
10.4.2 France Liposome Technology Service 麻豆原创 Forecast
10.4.3 UK Liposome Technology Service 麻豆原创 Forecast
10.4.4 Italy Liposome Technology Service 麻豆原创 Forecast
10.4.5 Russia Liposome Technology Service 麻豆原创 Forecast
10.5 Middle East & Africa Liposome Technology Service Forecast by Region (2025-2030)
10.5.1 Egypt Liposome Technology Service 麻豆原创 Forecast
10.5.2 South Africa Liposome Technology Service 麻豆原创 Forecast
10.5.3 Israel Liposome Technology Service 麻豆原创 Forecast
10.5.4 Turkey Liposome Technology Service 麻豆原创 Forecast
10.5.5 GCC Countries Liposome Technology Service 麻豆原创 Forecast
10.6 Global Liposome Technology Service Forecast by Type (2025-2030)
10.7 Global Liposome Technology Service Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 LIPOSOMA
11.1.1 LIPOSOMA Company Information
11.1.2 LIPOSOMA Liposome Technology Service Product Offered
11.1.3 LIPOSOMA Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 LIPOSOMA Main Business Overview
11.1.5 LIPOSOMA Latest Developments
11.2 CD Formulation
11.2.1 CD Formulation Company Information
11.2.2 CD Formulation Liposome Technology Service Product Offered
11.2.3 CD Formulation Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 CD Formulation Main Business Overview
11.2.5 CD Formulation Latest Developments
11.3 Creative Biostruct
11.3.1 Creative Biostruct Company Information
11.3.2 Creative Biostruct Liposome Technology Service Product Offered
11.3.3 Creative Biostruct Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Creative Biostruct Main Business Overview
11.3.5 Creative Biostruct Latest Developments
11.4 Echelon Biosciences
11.4.1 Echelon Biosciences Company Information
11.4.2 Echelon Biosciences Liposome Technology Service Product Offered
11.4.3 Echelon Biosciences Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Echelon Biosciences Main Business Overview
11.4.5 Echelon Biosciences Latest Developments
11.5 Encapsula Nanosciences
11.5.1 Encapsula Nanosciences Company Information
11.5.2 Encapsula Nanosciences Liposome Technology Service Product Offered
11.5.3 Encapsula Nanosciences Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Encapsula Nanosciences Main Business Overview
11.5.5 Encapsula Nanosciences Latest Developments
11.6 Toshiba
11.6.1 Toshiba Company Information
11.6.2 Toshiba Liposome Technology Service Product Offered
11.6.3 Toshiba Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Toshiba Main Business Overview
11.6.5 Toshiba Latest Developments
11.7 FUJIFILM Pharmaceuticals USA
11.7.1 FUJIFILM Pharmaceuticals USA Company Information
11.7.2 FUJIFILM Pharmaceuticals USA Liposome Technology Service Product Offered
11.7.3 FUJIFILM Pharmaceuticals USA Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 FUJIFILM Pharmaceuticals USA Main Business Overview
11.7.5 FUJIFILM Pharmaceuticals USA Latest Developments
11.8 Lifeasible
11.8.1 Lifeasible Company Information
11.8.2 Lifeasible Liposome Technology Service Product Offered
11.8.3 Lifeasible Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Lifeasible Main Business Overview
11.8.5 Lifeasible Latest Developments
11.9 PlantaCorp
11.9.1 PlantaCorp Company Information
11.9.2 PlantaCorp Liposome Technology Service Product Offered
11.9.3 PlantaCorp Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 PlantaCorp Main Business Overview
11.9.5 PlantaCorp Latest Developments
11.10 LIPOMIZE SRL
11.10.1 LIPOMIZE SRL Company Information
11.10.2 LIPOMIZE SRL Liposome Technology Service Product Offered
11.10.3 LIPOMIZE SRL Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 LIPOMIZE SRL Main Business Overview
11.10.5 LIPOMIZE SRL Latest Developments
11.11 Maison KOS脡
11.11.1 Maison KOS脡 Company Information
11.11.2 Maison KOS脡 Liposome Technology Service Product Offered
11.11.3 Maison KOS脡 Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Maison KOS脡 Main Business Overview
11.11.5 Maison KOS脡 Latest Developments
11.12 Microfluidics International Corporation
11.12.1 Microfluidics International Corporation Company Information
11.12.2 Microfluidics International Corporation Liposome Technology Service Product Offered
11.12.3 Microfluidics International Corporation Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Microfluidics International Corporation Main Business Overview
11.12.5 Microfluidics International Corporation Latest Developments
11.13 Exelead
11.13.1 Exelead Company Information
11.13.2 Exelead Liposome Technology Service Product Offered
11.13.3 Exelead Liposome Technology Service Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Exelead Main Business Overview
11.13.5 Exelead Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.